- Home
- KYMR vs CIFR Comparison
KYMR vs CIFR Comparison
Compare KYMR & CIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KYMR | CIFR |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | United States |
| Employees | N/A | 66 |
| Industry | Medicinal Chemicals and Botanical Products | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.3B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KYMR | CIFR |
|---|---|---|
| Price | $82.34 | $13.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 26 | 11 |
| Target Price | ★ $108.04 | $24.45 |
| AVG Volume (30 Days) | 710.3K | ★ 22.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,211,000.00 | N/A |
| Revenue This Year | $16.05 | $39.59 |
| Revenue Next Year | $4.79 | $192.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.45 | $1.86 |
| 52 Week High | $103.00 | $25.52 |
Technical Indicators
Market Signals| Indicator | KYMR | CIFR |
|---|---|---|
| Relative Strength Index (RSI) | 46.41 | 41.70 |
| Support Level | $77.78 | $13.84 |
| Resistance Level | $95.90 | $17.83 |
| Average True Range (ATR) | 4.43 | 1.36 |
| MACD | -1.11 | -0.17 |
| Stochastic Oscillator | 12.09 | 14.25 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About CIFR Cipher Mining Inc.
Cipher Digital Inc is focused on high-performance computing (HPC) data center development and operations. It is engaged in developing and operating data centers designed for HPC workloads. Its operations include managing power assets and capital allocation in response to market conditions and demand for AI-related computing capacity.